Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Commercial Launch Market Forecast 2029
September 12, 2024 07:49 ET
|
KuicK Research
Delhi, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029 Report: Report Answers...
Arteris Interconnect IP Selected by VeriSilicon for High-Performance SoC Design
September 10, 2024 09:00 ET
|
Arteris, Inc.
CAMPBELL, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that VeriSilicon...
Tenstorrent와 Movellus, 차세대 칩렛 기반의 AI 및 HPC 솔루션 발전 위한 전략적 파트너십 체결
September 09, 2024 22:29 ET
|
Movellus
양사 협력 통해 전력 및 성능 최적화를 위한 크로스 파운드리 IP 활성화 전망 서니베일, 캘리포니아, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus와 Tenstorrent가 전략적 제휴의 일환으로 Tenstorrent의 AI 및 HPC 칩렛 솔루션 부문에 Movellus의 디지털 IP 제품군 사용이 가능한 라이선스를...
Tenstorrent 和 Movellus 建立戰略合作關係，推動新一代小晶片為主的 AI 和高效能運算解決方案
September 09, 2024 22:29 ET
|
Movellus
加州桑尼維爾, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus 和 Tenstorrent 宣布，Tenstorrent 已經授權 Movellus 的數碼 IP 系列，作為其 AI 和高效能運算小晶片解決方案戰略合作的一部分。 是次合作旨在充分發揮兩家公司的優勢，開發小晶片為主的解決方案，以提升性能並優化功率。 Movellus Aeonic...
Tenstorrent 与 Movellus 达成战略合作，共同开发下一代基于芯粒的 AI 和 HPC 解决方案
September 09, 2024 22:29 ET
|
Movellus
加州森尼维尔, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Movellus 和 Tenstorrent 宣布，作为战略合作的一部分，Tenstorrent 已获得 Movellus 数字 IP 系列的授权，用于其 AI 和 HPC 解决方案。 此次合作旨在利用双方公司的优势，开发基于芯粒的解决方案，以在优化功耗的同时增强性能。 Movellus Aeonic 数字...
Interfield Global Software Inc. Provides Update Regarding Its Definitive License Agreement With JRL Energy Inc.
September 09, 2024 17:00 ET
|
Interfield Global Software Inc.
NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. ...
Tenstorrent and Movellus Form Strategic Engagement for Next-Generation Chiplet-Based AI and HPC Solutions
September 09, 2024 09:00 ET
|
Movellus
Movellus and Tenstorrent announced that Tenstorrent has licensed Movellus’ digital IP family as part of a strategic engagement, for its AI and HPC chiplets
Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check
September 09, 2024 08:30 ET
|
Femasys Inc.
ATLANTA, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
September 04, 2024 07:30 ET
|
iRhythm
SAN FRANCISCO, Sept. 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and...
Psyence Biomed Announces Worldwide Exclusive Licensing Agreement with PsyLabs to Supply Nature-Derived Psilocybin to be Evaluated as a Potential Treatment for Alcohol Use Disorder (AUD) and Other Substance Use Disorders (SUDs)
September 04, 2024 07:30 ET
|
Psyence Biomedical Ltd.
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM, PBMWW) (“Psyence Biomed” or the “Company”) today announced that the Company has entered into a worldwide, exclusive...